An assessment of effectiveness of Abhijeet Tail Nasya Viddhakarma and Antioxidant Therapy with Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration(Dry Type).A Randomized Controlled Clinical Trial.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 72
- 试验地点
- 1
- 主要终点
- Abhijeet Tail Nasya,Viddhakarma and Antioxidant Therapy is significantly effective than Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration (Dry Type).
研究概览
简要总结
this is a randomized controlled clinical trial assessing the effectiveness of abhijeet tail nasya,viddhakarma and antioxidant with antioxidant therapy only given for 21 days in 72 patients. Patients will be observed for 42 days.
the primary outcome is to see the effect of treatment on vataja timir (A.R.M.D) symptoms.
secondary outcome is to see effect on visual acuity, amsler grid, Pelli Robson chart contrast sensitivity chart.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 50.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients with distant vision less than or equal to 6/9 with symptoms like Bhramativa Darshana (objects seems to be moving), Aavila Darshana (blur vision),Vyavidha Darshana (metamorphopsia) will be taken.
排除标准
- •1.retinal diseases except ARMD dry type.
- •2.systemic diseases which affect macula like uncontrolled DM,hypertension,HIV,HbsAg diseases, psychiatric disorders 3.cataract patients.
- •4.Patients contraindicated for Nasya and siravedha.
- •5.patient with skin diseases.
结局指标
主要结局
Abhijeet Tail Nasya,Viddhakarma and Antioxidant Therapy is significantly effective than Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration (Dry Type).
时间窗: follow up on 0th,7th,14th,21st,28th,42nd day
次要结局
- Abhijeet Tail Nasya,Viddhakarma and Antioxidant Therapy is not significantly effective than Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration (Dry Type).(follow up on day 0th,7th,14th,21st,28th,42nd day)
研究者
Dr Siddhi Dichwalkar
Maharashtra University health science, Nashik
